Enteral connectors and systems

Details for Australian Patent Application No. 2010247839 (hide)

Owner Abbott Laboratories

Inventors Kropczynski, John; Perry, James; Walter, Meghan; Kopilec, Dennis; Cameron, Allan; Ciccone, Christine; Parent, Thomas; Stonecipher, Brian; Walker, Philip; Wilson, James

Agent Spruson & Ferguson

Pub. Number AU-A-2010247839

PCT Pub. Number WO2010/132427

Priority 61/176,964 11.05.09 US; 61/295,883 18.01.10 US; 61/246,200 28.09.09 US

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

A61M 39/10 (2006.01) Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use

A61J 1/10 (2006.01) Containers specially adapted for medical or pharmaceutical purposes - Bag-type containers

A61M 5/162 (2006.01) Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way

A61M 39/14 (2006.01) Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use

A61M 5/00 (2006.01) Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way

A61M 39/00 (2006.01) Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/132427 Priority application(s): WO2010/132427

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247842-Mattress edge sewing machine

2010247835-Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors